Cassava Sciences' stock fell after Phase 3 simufilam trial failed to meet key endpoints, prompting the discontinuation of its Alzheimer's studies.

Live Nation Entertainment LYV has outperformed the market over the past 15 years by 9.98% on an annualized basis producing an ...

Buying $100 In TTD: If an investor had bought $100 of TTD stock 5 years ago, it would be worth $492.52 today based on a price ...

Teledyne Technologies TDY -0.64% Get Free Report has outperformed the market over the past 20 years by 6.42% on an annualized ...

Analysts estimate that Arrowhead Pharma will report an earnings per share (EPS) of $-1.05. The market awaits Arrowhead Pharma's announcement, with hopes high for news of surpassing estimates and ...

Buying $1000 In WING: If an investor had bought $1000 of WING stock 5 years ago, it would be worth $4,220.00 today based on a ...

Enveric Biosciences completed preclinical PK studies for EB-003, a DMT analog targeting depression and anxiety without ...

BBWI shares up after reporting better than expected Q3 results and raising 2024 outlook. Sales and earnings beat analyst estimates.

Despite Bitcoin nearly hitting the $100,000 milestone, its recent price stagnation and social sentiment dip suggest a rise in ...

The earnings results for Alarum Technologies ALAR for Q3 were made public on Monday, November 25, 2024 at 07:30 AM. Here's a comprehensive overview of the announcement. Alarum Technologies beat ...

Macy's reports 3Q preliminary results with a 2.4% decline in net sales, weak performance in non-First 50 locations and ...

Palantir Technologies Inc. PLTR +3.51% Get Free Report experienced a 3.25% increase in pre-market trading on Monday, as per ...